Vaxcyte, Inc.
Public company- Headquarters
- SAN CARLOS, California
- Industry
- Biotechnology
- Ticker
- PCVX
- CIK
- 0001649094
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CLODavid McAvoy | Sep 3, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
- Executive appointment
CLO appointed: David McAvoy
David McAvoy was named Chief Legal Officer, Chief Compliance Officer, and Corporate Secretary of Vaxcyte, Inc., effective August 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 3, 2026Role: Chief Legal Officer, Chief Compliance Officer, and Corporate Secretary
Only one public record so far. We add events as soon as a new filing lands; watch Vaxcyte, Inc. to get them in your digest.
Last verified Nov 8, 2026